Literature DB >> 23180347

Therapeutic management of epithelial ovarian cancer during pregnancy.

L Minig1, L Otaño, I Diaz-Padilla, R Alvarez Gallego, M G Patrono, J Valero de Bernabé.   

Abstract

Epithelial ovarian cancer (EOC) during pregnancy is a rare condition. The diagnosis and treatment strategies are therefore not well defined. The evidence is scarce and limited to small case reports or case series. In this review we describe the safety, utility and limitations of each diagnostic tool and surgical procedure in pregnant women with ovarian cancer. We also discuss the role of chemotherapy for ovarian cancer during pregnancy. Finally, we delineate different strategies of treatment according to the stage of the disease at diagnosis and gestational age. Due to the complexity of the management of EOC during pregnancy, patients should be referred to specialized centers. Gestational age at diagnosis, the initial surgical procedure, disease stage and patient's preferences are the key factors in the decision-making process to establish the best treatment strategy for each individual case.

Entities:  

Mesh:

Year:  2012        PMID: 23180347     DOI: 10.1007/s12094-012-0963-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  40 in total

Review 1.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

Review 2.  Taxanes for breast cancer during pregnancy: a systematic review.

Authors:  O Mir; P Berveiller; F Goffinet; J-M Treluyer; R Serreau; F Goldwasser; R Rouzier
Journal:  Ann Oncol       Date:  2009-11-03       Impact factor: 32.976

3.  Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women.

Authors:  F Kobayashi; N Sagawa; K Nakamura; M Nonogaki; C Ban; S Fujii; T Mori
Journal:  Am J Obstet Gynecol       Date:  1989-03       Impact factor: 8.661

4.  FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.

Authors: 
Journal:  Teratology       Date:  1994-06

Review 5.  Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review.

Authors:  Gabriella Ferrandina; Mariagrazia Distefano; Antonia Testa; Rosa De Vincenzo; Giovanni Scambia
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

6.  Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary.

Authors:  C E Henderson; G Elia; D Garfinkel; M C Poirier; H Shamkhani; C D Runowicz
Journal:  Gynecol Oncol       Date:  1993-04       Impact factor: 5.482

Review 7.  Use of platinum derivatives during pregnancy.

Authors:  Olivier Mir; Paul Berveiller; Stanislas Ropert; François Goffinet; François Goldwasser
Journal:  Cancer       Date:  2008-12-01       Impact factor: 6.860

8.  Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes.

Authors:  Kristel Van Calsteren; Liesbeth Heyns; Frank De Smet; Liesbet Van Eycken; Mina Mhallem Gziri; Willemijn Van Gemert; Michael Halaska; Ignace Vergote; Nelleke Ottevanger; Frédéric Amant
Journal:  J Clin Oncol       Date:  2009-10-19       Impact factor: 44.544

9.  Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature.

Authors:  T Tabata; K Nishiura; K Tanida; E Kondo; T Okugawa; N Sagawa
Journal:  Int J Gynecol Cancer       Date:  2007-04-26       Impact factor: 3.437

Review 10.  Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature.

Authors:  Claes Tropé; Janne Kaern
Journal:  J Clin Oncol       Date:  2007-07-10       Impact factor: 44.544

View more
  11 in total

1.  Breast Cancer in Pregnancy: Avoiding Fetal Harm When Maternal Treatment Is Necessary.

Authors:  Christina N Cordeiro; Mary L Gemignani
Journal:  Breast J       Date:  2017-02-13       Impact factor: 2.431

2.  Ovarian cancer diagnosed during pregnancy: clinicopathological characteristics and management.

Authors:  C Grigoriadis; M Eleftheriades; T Panoskaltsis; A M Bacanu; N Vitoratos; A Kondi-Pafiti; A Tsangkas; A Tympa; D Hassiakos
Journal:  G Chir       Date:  2014 Mar-Apr

3.  Malignant Ovarian Tumors During Pregnancy: A Multicenter Retrospective Analysis.

Authors:  Liya Wang; Shenjiao Huang; Xiujie Sheng; Chenchen Ren; Qiming Wang; Linqing Yang; Shuping Zhao; Tianmin Xu; Xiaoxin Ma; Ruixia Guo; Pengming Sun; Yang Lin; Yuhong Li; Jiandong Wang; Yudong Wang
Journal:  Cancer Manag Res       Date:  2020-10-29       Impact factor: 3.989

4.  MicroRNA-298 inhibits malignant phenotypes of epithelial ovarian cancer by regulating the expression of EZH2.

Authors:  Fenmei Zhou; Juan Chen; Hairong Wang
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

Review 5.  A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives.

Authors:  Stergios Boussios; Michele Moschetta; Konstantina Tatsi; Alexandros K Tsiouris; Nicholas Pavlidis
Journal:  J Adv Res       Date:  2018-03-06       Impact factor: 10.479

Review 6.  Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety.

Authors:  Christina N Cordeiro; Mary L Gemignani
Journal:  Obstet Gynecol Surv       Date:  2017-03       Impact factor: 2.347

7.  MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.

Authors:  Minfei Jin; Zujing Yang; Weiping Ye; Hongling Xu; Xiaolin Hua
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

Review 8.  Investigation and Management of Adnexal Masses in Pregnancy.

Authors:  João Cavaco-Gomes; Cátia Jorge Moreira; Anabela Rocha; Raquel Mota; Vera Paiva; Antónia Costa
Journal:  Scientifica (Cairo)       Date:  2016-03-28

9.  Current management of gynecologic cancer in pregnancy

Authors:  Christos Iavazzo; Evelyn Eleni Minis; Ioannis D Gkegkes
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-04-27

10.  Long-term multidisciplinary integrative therapy management resulted in favorable outcomes for ovarian cancer during pregnancy: a case report and literature review.

Authors:  Tianmin Xu; Liang Wang; Yan Jia; Zanhui Jia; Zhuo Li; Shaohai Cui; Manhua Cui
Journal:  J Ovarian Res       Date:  2019-11-11       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.